fenoldopam has been researched along with Arteriosclerosis, Coronary in 2 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pittarello, D | 1 |
| Bonato, R | 1 |
| Falasco, G | 1 |
| Tiberio, I | 1 |
| Gasparetto, M | 1 |
| Ori, C | 1 |
| Briguori, C | 1 |
| Colombo, A | 1 |
| Airoldi, F | 1 |
| Violante, A | 1 |
| Castelli, A | 1 |
| Balestrieri, P | 1 |
| Paolo Elia, P | 1 |
| Golia, B | 1 |
| Lepore, S | 1 |
| Riviezzo, G | 1 |
| Scarpato, P | 1 |
| Librera, M | 1 |
| Focaccio, A | 1 |
| Ricciardelli, B | 1 |
2 trials available for fenoldopam and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effects of fenoldopam on myocardial function (strain rate) in patients with coronary artery disease undergoing cardiac surgery.
Topics: Aged; Antihypertensive Agents; Cardiac Surgical Procedures; Coronary Artery Disease; Female; Fenoldo | 2010 |
N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.
Topics: Acetylcysteine; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Coronary Artery Di | 2004 |